After the launch of China's new Foreign Investment Law, multinational pharmaceutical company Allergan found that local governments have been more open, transparent and efficient in the company's cooperation with them, which made investing in China more easy and smooth, said Wang Wei, area VP of Allergan Aesthetics JAPAC.

Wang also affirmed the company's confidence in China's economy and its market potential, betting on the country's large-base middle-class, well-trained workforce and people's high morality, believing they can overcome even the most trying challenge, like the COVID-19 outbreak.